RE:ASGPersonally, I like the direction it is taking.
It will take more time though unless they can further push the increased sales - which I think they are doing.
From Q1 financials:
In 2016, the company will focus on:
- Aggressively continuing strategy of building a revenue base in the North American and European markets; the company will accomplish this by expanding product usages with its current distribution network, developing new distribution channels and training new surgeons on the Aurora product advantages;
- Expanding sales teams in the United States by region
| Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
SALES | 1,549,125 | 1,495,319 | 1,173,017 | 934,145 | 1,298,144 |
Cost of goods sold | 744,094 | 731,166 | 429,875 | 425,945 | 622,518 |
GROSS PROFIT | 805,031 | 764,153 | 743,142 | 508,200 | 675,626 |
GROSS MARGIN | 52.0% | 51.1% | 63.4% | 54.4% | 52.0% |
| | | | | |
Gain on extinguishment of debt | 205,316 | | | |
| 805,031 | 969,469 | | | |
| | | | | |
OPERATING EXPENSES | | | | |
Executive compensation | 106,792 | 85,141 | 120,532 | 166,756 | 171,357 |
Salaries | 313,642 | 342,278 | 338,890 | 351,455 | 456,824 |
Consulting fees | 57,248 | 32,731 | 19,580 | 22,191 | 22,976 |
General and administrative | 153,014 | 267,918 | 295,546 | 21,714 | 641,362 |
Research and development | 8,408 | 21,858 | 4,440 | 11,044 | 40,777 |
Bad Debt | | | | | |
Marketing | 6,312 | 194,292 | 25,309 | 44,666 | 23,414 |
Occupancy | 57,072 | 65,166 | 63,669 | 72,865 | 62,299 |
Professional fees | 103,822 | 26,027 | 189,227 | -36,026 | 233,795 |
Stock based compensation | 44,615 | 50,884 | 50,884 | 50,884 | 40,789 |
Insurance | 69,819 | 91,080 | 61,223 | 63,709 | 85,298 |
Depreciation | 190,501 | 190,500 | 188,964 | 178,154 | 181,707 |
TOTAL OPERATING EXPENSES | 1,111,245 | 1,367,875 | 1,358,264 | 947,412 | 1,960,598 |
| | | | | |
NET LOSS | -306,214 | -603,722 | -615,122 | -439,212 | -1,284,972 |